These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 4675267)

  • 1. Carbohydrate structure in factor VIII.
    Austen DE; Bidwell E
    Thromb Diath Haemorrh; 1972 Dec; 28(3):464-72. PubMed ID: 4675267
    [No Abstract]   [Full Text] [Related]  

  • 2. Factor VIII structure and proteolytic processing.
    Eaton DL; Vehar GA
    Prog Hemost Thromb; 1986; 8():47-70. PubMed ID: 3104988
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comparative protein chemistry studies on Factor VIII concentrates].
    Kienast K; Trobisch H
    Arzneimittelforschung; 1984; 34(8):895-900. PubMed ID: 6437415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bovine factor VIII. Antigens and biological activities (author's transl)].
    Casillas G; Simonetti C; Pavlovsky A
    Sangre (Barc); 1977; 22(6):238-48. PubMed ID: 601671
    [No Abstract]   [Full Text] [Related]  

  • 5. Relation of factor VIII and IX inhibitors with ABO blood groups in 150 patients with haemophilia A and B.
    Torghabeh HM; Pourfathollah A; Shooshtari MM; Yazdi ZR
    Iran J Allergy Asthma Immunol; 2006 Mar; 5(1):33-4. PubMed ID: 17242502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High prevalence of elevated factor VIII levels in patients referred for thrombophilia screening: role of increased synthesis and relationship to the acute phase reaction.
    O'Donnell J; Tuddenham EG; Manning R; Kemball-Cook G; Johnson D; Laffan M
    Thromb Haemost; 1997 May; 77(5):825-8. PubMed ID: 9184386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation and some chemical properties of human factor VIII (antihemophilic factor).
    Hershgold EJ; Davison AM; Janszen ME
    J Lab Clin Med; 1971 Feb; 77(2):185-205. PubMed ID: 4993260
    [No Abstract]   [Full Text] [Related]  

  • 8. [Raised factor VIII and ABO system as thrombotic risk factors].
    Iturbe Hernández T; Cornudella Lacasa R; Recaséns Flores V; Romero Colás MS
    Med Clin (Barc); 2002 Nov; 119(19):754-5; author reply 755. PubMed ID: 12487974
    [No Abstract]   [Full Text] [Related]  

  • 9. The relationship between coagulation factor VIII and ABO blood group status.
    McLellan DS; Knight SR; Aronstam A
    Med Lab Sci; 1988 Apr; 45(2):131-4. PubMed ID: 3145379
    [No Abstract]   [Full Text] [Related]  

  • 10. Characterization of a form of bovine factor VIII which does not aggregate human platelets.
    Kirby EP
    Thromb Haemost; 1981 Aug; 46(2):479-84. PubMed ID: 6795738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Major blood group antigens--a determinant of factor VIII levels in blood?
    Mohanty D; Ghosh K; Marwaha N; Kaur S; Chauhan AP; Das KC
    Thromb Haemost; 1984 Jul; 51(3):414. PubMed ID: 6437009
    [No Abstract]   [Full Text] [Related]  

  • 12. Factor VIII levels and blood group antigens.
    McCallum CJ; Peake IR; Newcombe RG; Bloom AL
    Thromb Haemost; 1983 Oct; 50(3):757. PubMed ID: 6417823
    [No Abstract]   [Full Text] [Related]  

  • 13. Surface labelling as a tool to determine structure-function relationships of platelet plasma membrane glycoproteins.
    Phillips DR
    Thromb Haemost; 1980 Feb; 42(5):1638-51. PubMed ID: 6768157
    [No Abstract]   [Full Text] [Related]  

  • 14. Relationship between ABO and Secretor genotype with plasma levels of factor VIII and von Willebrand factor in thrombosis patients and control individuals.
    Schleef M; Strobel E; Dick A; Frank J; Schramm W; Spannagl M
    Br J Haematol; 2005 Jan; 128(1):100-7. PubMed ID: 15606555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Structure of carbohydrate chains of glycoproteins and methods of its study].
    Krotkiewski H
    Postepy Biochem; 1982; 28(4):433-63. PubMed ID: 6764807
    [No Abstract]   [Full Text] [Related]  

  • 16. Factor VIII, factor IX and fibrinogen content in cryoprecipitate, fresh plasma and cryoprecipitate-removed plasma.
    Bejrachandra S; Chandanayingyong D; Visudhiphan S; Tumliang S; Kaewkamol K; Siribunrit U
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():162-4. PubMed ID: 7886562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The half-life of infused factor VIII is shorter in hemophiliac patients with blood group O than in those with blood group A.
    Vlot AJ; Mauser-Bunschoten EP; Zarkova AG; Haan E; Kruitwagen CL; Sixma JJ; van den Berg HM
    Thromb Haemost; 2000 Jan; 83(1):65-9. PubMed ID: 10669157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The distribution of water-soluble blood group A antigen in the human large intestine: a mosaic pattern.
    Sanders EM; Kent SP
    Lab Invest; 1970 Jul; 23(1):74-8. PubMed ID: 4914454
    [No Abstract]   [Full Text] [Related]  

  • 19. Factor VIII inhibitors: structure and function in autoantibody and hemophilia A patients.
    Hoyer LW; Scandella D
    Semin Hematol; 1994 Apr; 31(2 Suppl 4):1-5. PubMed ID: 7524160
    [No Abstract]   [Full Text] [Related]  

  • 20. [Development of a competitive enzyme immunoassay for factor VIII-related antigen].
    Riemer J; Kopperschläger G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(1):72-83. PubMed ID: 6202602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.